Profil
Richard Fahrner worked as the Vice President-Pharmaceutical Development at Ra Pharmaceuticals, Inc. from 2015 to 2019.
He holds a doctorate degree from the University of California, Los Angeles and an undergraduate degree from California State University-Fullerton.
Anciens postes connus de Richard Fahrner
| Sociétés | Poste | Fin |
|---|---|---|
| RA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2019 |
Formation de Richard Fahrner
| University of California, Los Angeles | Doctorate Degree |
| California State University-Fullerton | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Ra Pharmaceuticals, Inc.
 Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA. | Health Technology |
